Vision & Mission
Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology
Arctic Vision announced its $32mn Series A financing led by Morningside Ventures, Nan Fung Life Sciences and Pivotal BioVenture Partners China.
Arctic Vision Announces Formation of Scientific Advisory Board
Arctic Vision announced today the formation of its Scientific Advisory Board comprised of three world-class ophthalmologists.
Clearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea
Arctic Vision to Lead Expansion of Novel Approach to Treating Macular Edema Associated with Uveitis in Asia
Fresh Eye On Ophthalmology: An Interview with the CEO Eddy Wu
An interview with Eddy Wu by The Croucher Foundation, an independent foundation dedicated to promoting sciences, technology and medicine in Hong Kong.